These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12398879)

  • 1. Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation.
    Milano CA; Patel VS; Smith PK; Smith MS
    J Heart Lung Transplant; 2002 Oct; 21(10):1127-30. PubMed ID: 12398879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation.
    Goldstein DJ; Oz MC; Smith CR; Friedlander JP; De Rosa CM; Mongero LB; Delphin E
    Ann Thorac Surg; 1996 Feb; 61(2):692-5. PubMed ID: 8572789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anaphylactic reaction after primary exposure to an aprotinin test dose in a child with a severe milk allergy.
    Kaddoum RN; Chidiac EJ; Zestos MM; Rajan SD; Baraka A
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):243-4. PubMed ID: 17418739
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylactic reaction to aprotinin.
    Ceriana P; Maurelli M; Locatelli A; Bianchi T; Maccario R; De Amici M
    J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):477-8. PubMed ID: 7579123
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant.
    Kober BJ; Scheule AM; Voth V; Deschner N; Schmid E; Ziemer G
    Anesth Analg; 2008 Aug; 107(2):406-9. PubMed ID: 18633016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery.
    Dietrich W; Ebell A; Busley R; Boulesteix AL
    Ann Thorac Surg; 2007 Oct; 84(4):1144-50. PubMed ID: 17888960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylaxis from aprotinin re-exposure during heart transplantation.
    Toleva O; Cheung A; Ignaszewski A
    J Heart Lung Transplant; 2007 Sep; 26(9):962-3. PubMed ID: 17845939
    [No Abstract]   [Full Text] [Related]  

  • 8. Case 4-2007. Aprotinin-induced cardiovascular collapse after a negative test dose in a patient scheduled for repeat mitral valve surgery.
    Beaulieu PL; Gandhi SD; Iqbal Z; Butler EG; Almassi GH; Pagel PS; Levy JH
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):597-601. PubMed ID: 17678797
    [No Abstract]   [Full Text] [Related]  

  • 9. Aprotinin in staged heart transplantation: anaphylactic potential of repeated exposure.
    Martinelli L; Maurelli M; Viganò M
    Ann Thorac Surg; 1996 Apr; 61(4):1288-9. PubMed ID: 8607713
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraoperative Anaphylaxis to Chlorhexidine During LVAD and Transplant Surgery.
    Zhou E; Parikh PS; Kanchuger MS; Balsam LB
    J Cardiothorac Vasc Anesth; 2019 Jan; 33(1):169-172. PubMed ID: 29859756
    [No Abstract]   [Full Text] [Related]  

  • 11. Aprotinin in lung transplantation is associated with an increased incidence of primary graft dysfunction.
    Marasco SF; Pilcher D; Oto T; Chang W; Griffiths A; Pellegrino V; Chan J; Bailey M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):420-5. PubMed ID: 19767212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for latex allergy. Diagnostic methods for aprotinin allergy].
    Pecquet C
    Ann Fr Anesth Reanim; 2002 May; 21 Suppl 1():123s-128s. PubMed ID: 12091978
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations.
    Dietrich W; Späth P; Ebell A; Richter JA
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):194-201. PubMed ID: 9011690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hypersensitivity reactions.
    Dietrich W
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S60-4; discussion S74-6. PubMed ID: 9647141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies.
    Dietrich W; Späth P; Zühlsdorf M; Dalichau H; Kirchhoff PG; Kuppe H; Preiss DU; Mayer G
    Anesthesiology; 2001 Jul; 95(1):64-71; discussion 5A-6A. PubMed ID: 11465586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in quality of life from after left ventricular assist device implantation to after heart transplantation.
    Grady KL; Meyer PM; Dressler D; White-Williams C; Kaan A; Mattea A; Ormaza S; Chillcott S; Loo A; Todd B; Costanzo MR; Piccione W
    J Heart Lung Transplant; 2003 Nov; 22(11):1254-67. PubMed ID: 14585387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe anaphylactic reaction after primary exposure to aprotinin.
    Cohen DM; Norberto J; Cartabuke R; Ryu G
    Ann Thorac Surg; 1999 Mar; 67(3):837-8. PubMed ID: 10215242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of preformed aprotinin-specific antibodies in cardiosurgical patients.
    Scheule AM; Beierlein W; Arnold S; Eckstein FS; Albes JM; Ziemer G
    Anesth Analg; 2000 Feb; 90(2):262-6. PubMed ID: 10648304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity reactions to aprotinin re-exposure in paediatric surgery.
    Siehr S; Stuth E; Tweddell J; Hoffman G; Troshynski T; Jones D; Mitchell M; Ghanayem N
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):307-11. PubMed ID: 19767215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.